NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/26/2025
Back to search
Official data from USPTO
ALL SYNDROMES KNOWN TO MAN EVALUATOR
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ALL SYNDROMES KNOWN TO MAN EVALUATOR
ST13
US500000087896266Class
38, 42, 44
Filing
87896266
Registration
5778990
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
09/27/2025
Trademark type
Word
Nice classes
38, 42, 44
Filing date
04/27/2018
Registration date
06/18/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/26/2025
Last transaction
09/27/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
09/03/2016
First use in commerce
09/03/2016
Drawing code
4
Owner type
54
Owner location
Boston, MA
Examiner
LAPTER,ALAIN J
Current location
Historical data usage
Holders and representatives
Holders
Dana-Farber Cancer Institute, Inc.
Representatives
Douglas R. Wolf Wolf, Greenfield & Sacks, P.C.
Technical classification
Nice Classes
Class 38Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 38
providing multiple user access to a platform for providing risk analysispredictiontreatmentmanagement guidelines in the field of gene mutations
Class 42
medical and scientific research services in the field of cancer; providing temporary use of non-downloadable software for providing risk analysispredictiontreatmentmanagement guidelines in the field of gene mutations
Class 44
providing information in the fields of cancer treatment and care; medical treatment services in the field of cancer; hospital services; health care servicesnamely providing risk analysispredictiontreatment and disease management guidelines in the field of gene mutations
Publications
History of USPTO decisions and trademark events.
26 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/26/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/26/2025
E815
TEAS SECTION 8 & 15 RECEIVED
05/15/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/18/2024
NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
04/02/2024
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
02/27/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/13/2024
ES7R
TEAS SECTION 7 REQUEST RECEIVED
06/16/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/10/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/10/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
06/18/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/02/2019
PUBO
PUBLISHED FOR OPPOSITION
04/02/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/13/2019
ALIE
ASSIGNED TO LIE
02/25/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/08/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/07/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/07/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/07/2019
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
08/07/2018
GPRA
PRIORITY ACTION E-MAILED
08/07/2018
CPRA
PRIORITY ACTION WRITTEN
08/07/2018
DOCK
ASSIGNED TO EXAMINER
08/06/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/05/2018
NWAP
NEW APPLICATION ENTERED
05/01/2018
Continuous trademark protection
Get notified about every new filing that threatens ALL SYNDROMES KNOWN TO MAN EVALUATOR or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.